Researchers identify strategy to design safer opioids

Opioid medications offer people relief from debilitating pain, but these drugs come with dangers: the risk for addiction, miserable withdrawal symptoms and the potential for fatal overdose.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

Omitting systematic biopsy in men with elevated prostate-specific antigen (PSA) levels and negative MRI results, and performing only targeted biopsy of MRI-positive lesions, eliminated more

September 26, 2024

Elucida Oncology nabs more funds for its take on ADCs, sees potential in radiotherapy partnership

Elucida Oncology has raised another approximately $30 million to bring its version of antibody-drug conjugates to more patients in the clinical setting, the company told

June 24, 2023

Embecta gets FDA nod for insulin patch pump

Dive Brief: Embecta received 510(k) clearance from the Food and Drug Administration on Friday for its first insulin patch pump. The device can be used

September 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.